These results indicate that AMPK pathway is involved in the regulation of metformin on GLP-1R level and PKA phosphorylation in PA-treated HUVECs
Insulin is associated with weight gain

At a glance GLP-1 medications are changing how consumers eat, with appetite suppression, smaller portions and altered taste preferences driving demand for nutrient-dense, high-protein foods Brands can lead through smarter reformulation, offering products fortified with protein, fibre and clean label sweeteners to help consumers stay nourished on fewer calories Improving nutrient density can drive opportunity high-protein, high fibre, portion-controlled foods and beverages align with new consumer priorities for long-term weight and wellness management Innovation spans multiple categories, with bakery, snacks and beverages being ideal platforms for nutrient-dense reformulations that balance functionality, taste and texture Ingredion's portfolio of resistant starches, prebiotic fibres, pulse proteins and low- and no-calorie sweeteners help formulators meet the evolving nutritional needs of consumers on GLP-1 based medications as well as those looking to manage their weight without pharmaceuticals Weight management trends are redefining nutrition and pushing brands to reformulate For food and beverage brands, this shift represents far more than a dietary trend

The pharma pipeline is rapidly expanding with multi-hormone combinations, new indications, and easier-to-use GLP-1 treatments poised to transform care
Because of that, the two products answer different workflow needs
Both bind to the GHRH receptor on the pituitary